 |
 |
|
|
|
| Indacaterol |
 |
| 5-[2-(5,6-Diethyl-2,3-dihydro-1H-inden-2-ylamino)-(1R)-hydroxyethyl]-8-hydroxyquinolin-2(1H)-one |
 |
| 312753-06-3 |
 |
| Indacaterol is an ultra-long-acting beta-adrenoceptor agonist. It is licensed only for the treatment of chronic obstructive pulmonary disease (COPD) (long-term data in patients with asthma are thus far lacking). |
 |
Grade Standard: Tech Grade
Purity: 99%
Molecular Formula: C24H28N2O3
Molecular Weight: 392.4907
Inchi: InChI=1/C24H28N2O3/c1-3-14-9-16-11-18(12-17(16)10-15(14)4-2)25-13-22(28)19-5-7-21(27)24-20(19)6-8-23(29)26-24/h5-10,18,22,25,27-28H,3-4,11-13H2,1-2H3,(H,26,29)
Density: 1.27g/cm3
Boiling point: 660.3¡ÆC at 760 mmHg
Refractive index: 1.659
Flash point: 353.1¡ÆC
Vapour Pressur: 2.47E-18mmHg at 25¡ÆC
|
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
